Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 1066

Results For "IT"

10807 News Found

Haffkine Biopharma to produce 22.8 Cr doses of Covaxin
News | June 03, 2021

Haffkine Biopharma to produce 22.8 Cr doses of Covaxin

For undertaking production, the company has been provided a Rs. 65 crore grant by the centre and Rs. 94 crore from the government of Maharashtra


Zydus Cadila receives tentative approval from USFDA for lung cancer drugs
Policy | June 03, 2021

Zydus Cadila receives tentative approval from USFDA for lung cancer drugs

Osimertinib works by slowing or stopping the growth of cancer cells and binds to a certain protein (epidermal growth factor receptor-EGFR) in some tumors


Glenmark Pharmaceuticals launches Rufinamide Tablets USP, 200 mg and 400 mg
News | June 02, 2021

Glenmark Pharmaceuticals launches Rufinamide Tablets USP, 200 mg and 400 mg

The Banzel Tablets, 200 mg and 400 mg market2 achieved annual sales of approximately $285.3 million.


Shilpa Medicare Q4FY21 consolidated PAT at Rs. 7.82 Cr
News | June 01, 2021

Shilpa Medicare Q4FY21 consolidated PAT at Rs. 7.82 Cr

The company has posted net profit of Rs.147.78 crores for the 12 months period ended March 31, 2021


Unilever to launch recyclable tubes for oral care in India
Packaging | June 01, 2021

Unilever to launch recyclable tubes for oral care in India

EPL will supply APR approved 100% recyclable and fully sustainable Platina Tubes for the toothpaste category of Unilever


Govt. to give 12 Cr COVID vaccine doses in June 2021
News | May 31, 2021

Govt. to give 12 Cr COVID vaccine doses in June 2021

7.94 crore doses were made available to the states in May 2021


SMS Pharmaceuticals posts Q4FY21 consolidated PAT of Rs. 22.21 Cr
News | May 29, 2021

SMS Pharmaceuticals posts Q4FY21 consolidated PAT of Rs. 22.21 Cr

It posted net profit of Rs.60.96 crores for the 12 months period ended March 31, 2021


TLC partners Strides to launch Mucormycosis drug in India
News | May 28, 2021

TLC partners Strides to launch Mucormycosis drug in India

Mucormycosis drug AmphoTLC will be imported from Taiwan by Stelis Biopharma Private Limited (Stelis), the biotech arm of Strides group, and will be launched and distributed in India immediately by Strides


Lupin receives US $50 mn on achieving cancer milestone
News | May 28, 2021

Lupin receives US $50 mn on achieving cancer milestone

MEK inhibitor compound (LNP3794) developed as part of its oncology pipeline had previously shown pre-clinical activity as a single agent as well as in combination


Remdesivir demand was exaggerated: Dr. Sharvil Patel
News | May 28, 2021

Remdesivir demand was exaggerated: Dr. Sharvil Patel

Dr. Sharvil Patel cites the example of prescriptions being handed over to patients despite unavailability of enough stock of such medicines